SCHEMBL3356851

SCHEMBL3356851

CCC=C(N)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
NPSR1 Q6W5P4 2/20 0.43
GLO1 Q04760 1/20 0.43
ALDH1A1 P00352 5/20 0.40
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2D6 P10635 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
SOAT1 P35610 1/20 0.37
EGLN1 Q9GZT9 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C9 P11712 2/20 0.36
HCAR2 Q8TDS4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28149018 0.83 ALOX15 (0.44) ALOX15NPSR1GLO1ALDH1A1LMNA
SCHEMBL3358508 0.83 HCAR2 (0.39) ALOX15NPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL9468281 0.83 ALOX15 (0.44) ALOX15NPSR1GLO1ALDH1A1LMNA
SCHEMBL6819424 0.81
SCHEMBL3357035 0.81
SCHEMBL7764105 0.81 ALOX15 (0.33) ALOX15
SCHEMBL14719755 0.79 ALOX15 (0.41) ALOX15NPSR1GLO1ALDH1A1LMNA
SCHEMBL3355790 0.79 ATM (0.48) NPSR1ALDH1A1LMNAHSD17B10CYP2D6
SCHEMBL4351912 0.79 FAAH (0.45) ALOX15NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL25435840 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114672267-B Adhesive film, optical member including the same, and optical display including the same 三星SDI株式会社 2024-03-12 CN disclosed
CN-116724095-A Adhesive film, optical member including the same, and optical display device including the same 三星SDI株式会社 2023-09-08 CN disclosed
EP-4213980-A1 AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES Encapsys, LLC (US) 2023-07-26 EP disclosed
WO-2022061103-A1 AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES ENCAPSYS, LLC (US) 2022-03-24 WO disclosed
CN-113164789-A Composition comprising an encapsulate 宝洁公司 2021-07-23 CN disclosed
US-20200392271-A1 ASSOCIATIVE POLYMER STRUCTURES AND METHODS OF USE THEREOF RHODIA OPERATIONS (FR) 2020-12-17 US disclosed
CN-102202700-B Polymeric material ROVI LAB FARMACEUT SA 2015-06-17 CN disclosed
US-8993112-B2 Polymeric particles BASF SE (DE) 2015-03-31 US disclosed
CN-102202700-A Polymeric material ROVI LAB FARMACEUT SA 2011-09-28 CN disclosed
EP-1756184-B1 POLYMERIC PARTICLES BASF SE (DE) 2010-01-13 EP disclosed
US-20070255008-A1 Polymeric Particles CIBA CORPORATION 2007-11-01 US disclosed
EP-1814924-A2 AMPHIPHILIC STAR BLOCK COPOLYMERS FIRMENICH SA (CH) 2007-08-08 EP disclosed
US-20070160561-A1 AMPHIPHILIC STAR BLOCK COPOLYMERS FIRMENICH SA (CH) 2007-07-12 US disclosed
EP-1756184-A1 POLYMERIC PARTICLES Ciba Specialty Chemicals Holding Inc. (CH) 2007-02-28 EP disclosed
WO-2006038110-A2 AMPHIPHILIC STAR BLOCK COPOLYMERS FIRMENICH SA (CH) 2006-04-13 WO disclosed
WO-2005123796-A1 POLYMERIC PARTICLES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070160561-A1 AMPHIPHILIC STAR BLOCK COPOLYMERS ABCB4, ABCB7, ABCC5 ALOX15 226/4885NPSR1 2264/4885GLO1 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.